Pink crisis, clear solution: how advanced mass spectrometry turned a manufacturing risk into success
Learn how KBI Biopharma used advanced mass spectrometry to address a cell culture media issue and prevent a potential manufacturing disruption.
- Latest Posts
News and Trends 23 Sep 2024
Vicebio and its molecular clamp vaccine raise big to tackle respiratory viruses
Discover Vicebio’s molecular clamp technology as it completes a $100 million series B round for its bivalent vaccine against RSV and hMPV.
In Depth 20 Sep 2024
Mitigating hot flashes: new therapies for menopause on the rise
New therapies could address menopause symptoms, a field in which many treatment gaps still exist.
Podcast 20 Sep 2024
Estonia’s biobank: Is this the first large-scale personalized medicine initiative?
Estonia is working on becoming the first country to implement personalized health at scale through the Estonian National Biobank.
In Depth 19 Sep 2024
Mitochondrial disease treatments: is a breakthrough on the horizon?
Mitochondrial dysfunction is linked to many diseases. Discover how biotechs are developing mitochondrial disease treatments to address these diseases.
Best in Biotech 19 Sep 2024
Six immunology biotech companies revolutionizing immune treatments in 2024
Find out more about six immunology companies that have recently raised impressive funds in the biotech industry.
ADVERTISEMENT
ADVERTISEMENT
In Depth 18 Sep 2024
Two targets, one solution: The rise of bispecific antibodies
Find out all you need to know about bispecific antibodies, including how they work and what the current clinical landscape looks like.
Best in Biotech 17 Sep 2024
Estonia: Seven biotech companies to reckon with
Explore Estonia’s biotech scene with 7 pioneering companies across Tallinn, Tartu, and beyond, fueled by top science parks and universities.
ADCs that deliver: The secret lies in rigorous characterization
Explore the challenges of ADC characterization, key techniques, and the benefits of partnering with a CDMO for effective development.
News and Trends 16 Sep 2024
Vironexis’ AAV vector approach: The next frontier in cancer immunology?
Delve into Vironexis’ launch with a pipeline of 10 cancer drug candidates built around its AAV vectors platform.
Expert Advice 13 Sep 2024
Stealth mode biotech startups: Everything you need to know
Discover all you need to know about stealth mode biotech startups, including what stealth mode is and its advantages and disadvantages.
Podcast 13 Sep 2024
Targeting inflammation: A revolution in disease treatment
NLRP3 inflammasome-induced inflammation is at the root of nearly all disease pathologies. Listen to our conversation with Halia Therapeutics about it.
ADVERTISEMENT
